Medical devices
10 Medtronic corporate development leaders
These ten current and former Medtronic corporate development leaders have held director through senior vice president roles in corporate development, business development and M&A at the company. A reader can learn how Medtronic approaches corporate development from people who led it.
Professionals to explore
01—10Ann Hickey
LinkedInExperience: Vice President Corporate Development, Medical Surgical · Medtronic
Former Vice President Corporate Development, Medical Surgical at Medtronic (2021–2025), after Vice President Strategy, Portfolio Management, and Business Development, MITG Group at Medtronic (2016–2021). They were Vice President Strategy and Business Development, Peripheral Vascular at Covidien (Medtronic Minimally Invasive Therapies Group) (2010–2014), and the listing shows them retired from Medtronic since 2025.
Bethany Tong
LinkedInExperience: Director Corporate Development · Medtronic
Former Director Corporate Development at Medtronic (2015–2018), after Sr. Manager, Corporate Development (2015). They were then Sr. Director, China Integration & Local Product Development, Spine (2018–2020) and Sr. Business Director/General Manager, Epilepsy and Laser Ablation Business (2020–2022), and since 2022 have been VP, Portfolio Management, Integration, Separation at Medtronic.
Chris Eso
LinkedInExperience: Senior Vice President, Global Head of Corporate and Buiness Development, M&A and Ventures · Medtronic
Senior Vice President, Global Head of Corporate and Buiness Development, M&A and Ventures at Medtronic since June 2026; the listing also shows them as Vice President, Global Head of Corporate and Business Development, M&A and Ventures (2024–2026). Earlier at Medtronic they were Vice President, M&A, Strategy & Portfolio Management, CardioVascular Portfolio & SH&A (2020–2023) and Vice President, M&A, Strategy and Portfolio Management, Cardiovascular Portfolio (2023–2024).
Chris King
LinkedInExperience: Senior Director, Corporate Development · Medtronic
Former Senior Director, Corporate Development at Medtronic (2005–2010), after Director, Investor Relations and Corporate Strategy at Medtronic (2003–2005). Since 2010 they have been Vice President, Business Development and Strategic Partnering at Medtronic, which the listing shows with no end date.
Dave Allen
LinkedInExperience: Vice President, Corporate and Business Development, Medical Surgical Portfolio · Medtronic
Vice President, Corporate and Business Development, Medical Surgical Portfolio at Medtronic since January 2025. Their profile says they lead a global team that defines strategy, manages the portfolio and evaluates inorganic growth opportunities, and have structured and closed more than 50 transactions. They were Vice President, Business Development & Strategy, Gastrointestinal and Medical Surgical Portfolio (2022–2025).
DJ Sardella
LinkedInExperience: Vice President - Corporate Development, Neuroscience & Diabetes · Medtronic
Vice President - Corporate Development, Neuroscience & Diabetes at Medtronic since February 2022, a current role listed at President/Vice President level. It is the only work row the listing shows for them, so the source does not describe earlier roles or specific transactions they worked on.
Matthew Kesanen
LinkedInExperience: Director, Business Development (M&A) · Medtronic
Former Director, Business Development (M&A) at Medtronic (2018–2021), after Financial Consultant, Business Development (M&A) (2016–2018). Their profile says they serve as a business partner to Medtronic's business development and corporate development functions across the M&A process, including deal structuring, financial due diligence and valuation. Since 2023 they have been Vice President, Portfolio Management at Medtronic.
Rajen Kumar
LinkedInExperience: Sr. Corporate Development Director · Medtronic
Sr. Corporate Development Director at Medtronic since January 2022, where their profile says they help manage and lead portfolio management workstreams, including integrations and divestitures, with senior leadership. Earlier at Medtronic they were Business Development Director (2020–2022), Program Manager - R&D (2018–2020), Program Manager - Marketing & Strategy (2016–2018) and Sr. R&D Engineer (2012–2016).
Sean Joseph
LinkedInExperience: Senior Director, Corporate Development & Enterprise Portfolio Management · Medtronic
Senior Director, Corporate Development & Enterprise Portfolio Management at Medtronic since September 2026, a Director-level role based in Atlanta. Before Medtronic they were Senior Director - Transaction Strategy and Execution (2021–2026) and Director - Transaction Strategy and Execution (2019–2021) at EY-Parthenon, and M&A Advisory Manager at PwC (2017–2019).
Shirley Martin
LinkedInExperience: Director Group M&A · Medtronic
Director Group M&A at Medtronic since July 2020, based in the Greater Paris region. Earlier at Medtronic they were Senior Finance Manager Group Capital Markets (2017–2020) and Senior Finance Manger Business Licensing and Partnership (2013–2017). Their profile describes experience in corporate finance, mergers and acquisitions and business partnerships.
Choose the right perspective
Match the person's portfolio and era to your question, since corporate development for cardiovascular, medical surgical or neuroscience businesses can involve different priorities and teams. Pick someone with a global or group M&A role for questions about how deals are run across the company, and someone with a portfolio role for questions about one business area.
Questions to take into the conversation
- 01How does a medical device company split corporate development work between a global team and its operating portfolios?
- 02What does a corporate development leader at a medtech company look at when evaluating inorganic growth opportunities?
- 03How do finance and M&A teams at a large medtech company work together on deal structuring and due diligence?
Reaching Medtronic corporate development leaders
How can I contact one of these Medtronic corporate development leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Medtronic, based on profile data retrieved on October 10, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Medtronic corporate development leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Medtronic corporate development leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal